Group One Trading’s Syneron Medical Ltd ELOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-500
Closed -$5K 5530
2017
Q2
$5K Sell
500
-5,000
-91% -$54.8K ﹤0.01% 4446
2017
Q1
$58K Buy
+5,500
New +$53.2K ﹤0.01% 3313
2016
Q4
Sell
-7,100
Closed -$51K 5147
2016
Q3
$51K Buy
7,100
+7,000
+7,000% +$48.7K ﹤0.01% 3348
2016
Q2
$1K Buy
+100
New +$713 ﹤0.01% 4552
2015
Q4
Sell
-2,500
Closed -$18K 5420
2015
Q3
$18K Buy
+2,500
New +$24K ﹤0.01% 4094
2015
Q1
Sell
-1,600
Closed -$15K 5504
2014
Q4
$15K Buy
1,600
+100
+7% +$964 ﹤0.01% 4089
2014
Q3
$15K Buy
+1,500
New +$15.3K ﹤0.01% 4283
2014
Q2
Sell
-900
Closed -$11K 5724
2014
Q1
$11K Buy
+900
New +$10.7K ﹤0.01% 4552
2013
Q3
Sell
-4,700
Closed -$41K 5871
2013
Q2
$41K Buy
+4,700
New +$42K ﹤0.01% 3608

Other funds holding ELOS

Group One Trading's ELOS Position: Q1 2017 in Review

Group One Trading sold out of Syneron Medical Ltd (ELOS) in Q1 2017, closing a stake of 9,870 shares — an estimated $95.5K sold.

Group One Trading first reported a position in ELOS in Q4 2013 and held it in 6 quarters. The position peaked at $83K in Q4 2016. 91 funds tracked by Wall St. Rank hold ELOS as of Q1 2017.

  • Group One Trading reported no remaining Syneron Medical Ltd position as of Q1 2017 after selling out during the quarter.
  • Group One Trading sold 9,870 Syneron Medical Ltd shares in Q1 2017, an estimated $95.5K.
  • Group One Trading first reported a position in Syneron Medical Ltd in Q4 2013 and held it in 6 quarters.
  • Group One Trading's Syneron Medical Ltd position peaked at $83K in Q4 2016.
  • 91 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q1 2017.

Based on Group One Trading's 13F filing for Q1 2017, filed 10 May 2017.